Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis
Authors
Keywords
-
Journal
Biomolecules
Volume 10, Issue 6, Pages 954
Publisher
MDPI AG
Online
2020-06-25
DOI
10.3390/biom10060954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential interventions for novel coronavirus in China: A systematic review
- (2020) Lei Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle
- (2020) Samantha Gildenhuys BIOCHEMICAL JOURNAL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- SARS-CoV-2: Combating Coronavirus Emergence
- (2020) Rachel L. Graham et al. IMMUNITY
- A Review of Coronavirus Disease-2019 (COVID-19)
- (2020) Tanu Singhal INDIAN JOURNAL OF PEDIATRICS
- Coronavirus disease 2019 (COVID-19): current status and future perspectives
- (2020) Heng Li et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Review of SARS-CoV-2 and the Ongoing Clinical Trials
- (2020) Yung-Fang Tu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach
- (2020) Salman Ali Khan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
- (2020) Anh-Tien Ton et al. Molecular Informatics
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
- (2020) Jiahua He et al. Viruses-Basel
- COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
- (2020) Kuldeep Dhama et al. Human Vaccines & Immunotherapeutics
- The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment
- (2020) Yuxin Yan et al. International Journal of Environmental Research and Public Health
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
- (2020) Erin K McCreary et al. Open Forum Infectious Diseases
- Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
- (2020) Muhammad Usman Mirza et al. Journal of Pharmaceutical Analysis
- Candidate drugs against SARS-CoV-2 and COVID-19
- (2020) Dwight L. McKee et al. PHARMACOLOGICAL RESEARCH
- The Retinoid and Non-Retinoid Ligands of the Rod Visual G Protein-Coupled Receptor
- (2019) Joseph T. Ortega et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- New and Future Drug Development for Gastroesophageal Reflux Disease
- (2014) Carla Maradey-Romero et al. Journal of Neurogastroenterology and Motility
- Plasma protein binding: From discovery to development
- (2013) Tonika Bohnert et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- HIV-1 Antiretroviral Drug Therapy
- (2013) E. J. Arts et al. Cold Spring Harbor Perspectives in Medicine
- High-Throughput parallel blind Virtual Screening using BINDSURF
- (2012) Irene Sánchez-Linares et al. BMC BIOINFORMATICS
- The structural biology of HIV-1: mechanistic and therapeutic insights
- (2012) Alan Engelman et al. NATURE REVIEWS MICROBIOLOGY
- Revisiting the General Solubility Equation: In Silico Prediction of Aqueous Solubility Incorporating the Effect of Topographical Polar Surface Area
- (2011) Jogoth Ali et al. Journal of Chemical Information and Modeling
- Plasma Protein Binding in Drug Discovery and Development
- (2010) Monique Howard et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields
- (2009) K. Vanommeslaeghe et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin
- (2008) Jane M. Sayer et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started